Trade Summary

1 week ago, Anderman Jonathan, serving as GC at Compass Therapeutics, Inc. (CMPX), purchased 25,000 shares at $1.89 per share, for a total transaction value of $47,250.00. Following this transaction, Anderman Jonathan now holds 196,000 shares of CMPX.

This purchase represents a 15.00% increase in Anderman Jonathan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, April 29, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 30, 2026, 1 day after the trade was made.

Compass Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.